Tenon Medical (TNON) Expected to Announce Quarterly Earnings on Wednesday

Posted by Editorial Team on Aug 12th, 2025

Tenon Medical (NASDAQ:TNON – Get Free Report) will likely be releasing its Q2 2025 earnings data after the market closes on Wednesday, August 13th. Analysts expect Tenon Medical to post earnings of ($0.47) per share and revenue of $0.91 million for the quarter.

Tenon Medical (NASDAQ:TNON – Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The company reported ($1.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.06) by $0.05. The firm had revenue of $0.73 million during the quarter, compared to the consensus estimate of $0.76 million. Tenon Medical had a negative return on equity of 558.92% and a negative net margin of 417.57%.

Tenon Medical Stock Down 0.7%

TNON stock opened at $1.38 on Tuesday. The business has a 50 day moving average price of $1.06 and a two-hundred day moving average price of $1.24. The company has a market cap of $10.47 million, a price-to-earnings ratio of -0.05 and a beta of 1.23. Tenon Medical has a twelve month low of $0.85 and a twelve month high of $15.79.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Tenon Medical stock. Jane Street Group LLC bought a new position in shares of Tenon Medical, Inc. (NASDAQ:TNON – Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 13,958 shares of the company’s stock, valued at approximately $29,000. Jane Street Group LLC owned 0.23% of Tenon Medical at the end of the most recent quarter. Institutional investors own 22.74% of the company’s stock.

Analyst Ratings Changes

Separately, Citigroup reiterated a “buy” rating on shares of Tenon Medical in a research note on Wednesday, May 14th.

Get Our Latest Research Report on TNON

Tenon Medical Company Profile

(Get Free Report)

Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.